News

The C-Suite EMR is a SaaS software solution that utilizes the cloud to ensure its ease of use, medical billing and practice management firm CSC said. CSC CEO

The placebo-controlled, double-blind study evaluates the safety, tolerability, and pharmacokinetics of RK-023 in healthy adult male and female volunteers, who will apply the study drug to the eyelid

The studies evaluated the effect of bafetinib on bone cells (osteoclasts) from multiple myeloma patients. The study results showed that in two model systems, bafetinib significantly suppressed the

The agreement requires Lundbeck to register and commercialise key products which are currently available in the US and/or Europe on behalf of Cephalon including Fentora (fentanyl buccal tablet)

The new labels now carry US prescribed information on medication guides, additional safety and restrictions on the use of these medicines for cardiovascular event data in type 2

The joint agreement resolves all legal disputes between the two companies, including those relating to UCB’s pegylated humanized antibody fragment, Cimzia (certolizumab pegol), and PDL’s Queen et al.

Vical is collaborating with the university’s School of Medicine and the Sealy Center for Vaccine Development under a previously disclosed grant on the preclinical development of an HSV-2

Boehringer Ingelheim will carry out the technical development, clinical manufacturing and all related regulatory filing support services for antibodies discovered by Elan. Elan will guide the discovery science,

POTELLIGENT CHOK1SV is a new host cell line for manufacturing recombinant antibodies. It combines the power of BioWa’s engineered glycosylation POTELLIGENT Technology with the advantages of Lonza’s proprietary